Combined values of serum albumin, C-reactive protein and body mass index at dialysis initiation accurately predicts long-term mortality

American Journal of Nephrology

Volumn 36, Issue 2, 2012, Pages 136-143

  Takahashi, Ryo ^a,b   Ito, Yasuhiko ^a,d   Takahashi, Hiroshi ^b   Ishii, Hideki ^a   Kasuga, Hirotake ^b   Mizuno, Masashi ^a   Suzuki, Yasuhiro ^a   Yuzawa, Yukio ^c   Maruyama, Shoichi ^a   Murohara, Toyoaki ^a   Imai, Enyu ^a   Matsuo, Seiichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nagoya Kyoritsu Hospital   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Albumin; BMI; Composite; CRP; CVD mortality; Survival

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; JAPANESE; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SURVIVAL RATE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN; TIME FACTORS;

EID: 84863879268     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000339940     Document Type: Article

References (27)

1. Stenvinkel P, Carrero JJ, Axelsson J, et al: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008;3:505-521.
2. Cheung AK, Sarnak MJ, Yan G, et al: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58:353-362. (Pubitemid 30429882)
3. Stenvinkel P, Lindholm B: C-reactive protein in end-stage renal disease: are there reasons to measure it? Blood Purif 2005;23:72-78. (Pubitemid 40082247)
4. Menon V, Greene T, Wang X, et al: C-reactive protein and albumin as predictors of allcause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005;68:766-772. (Pubitemid 43323132)
5. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658. (Pubitemid 29082891)
6. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482. (Pubitemid 20174016)
7. Friedman AN, Fadem SZ: Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol 2010;21:223-230.
8. Iseki K, Tozawa M, Yoshi S, Fukiyama K: Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999;14:1956-1960. (Pubitemid 29358894)
9. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, et al: Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 2005;46:489-500. (Pubitemid 41208185)
10. Kalantar-Zadeh K, Kuwae N, Wu DY, et al: Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 2006;83:202-210. (Pubitemid 44713179)
11. Huang CX, Tighiouart H, Beddhu S, et al: Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int 2010;77:624-629.
12. Ishii H, Toriyama T, Aoyama T, et al: Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimuseluting stents in patients on hemodialysis. Circ Cardiovasc Interv 2009;2:513-518.
13. Ishii H, Kumada Y, Toriyama T, et al: Prognostic values of C-reactive protein levels on clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease. J Vasc Surg 2010;52:854-859.
14. de Mutsert R, Snijder MB, van der Sman-de Beer F, et al: Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of followup. J Am Soc Nephrol 2007;18:967-974. (Pubitemid 46434514)
15. Zhang L, Kao WH, Berthier-Schaad Y, et al: C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. Am J Kidney Dis 2007;49:118-126. (Pubitemid 44932197)
16. Coe CL, Love GD, Karasawa M, et al: Population differences in proinflammatory biology: Japanese have healthier profiles than Americans. Brain Behav Immun 2011;25:494-502.
17. Oldroyd JC, Heald A, Bansal N, et al: Inflammatory markers and growth in South Asian and European origin infants in Britain: the Manchester Children's Growth and Vascular Health Study. Atherosclerosis 2009;207:227-231.
18. Wong JS, Port FK, Hulbert-Shearon TE, et al: Survival advantage in Asian American endstage renal disease patients. Kidney Int 1999;55:2515-2523. (Pubitemid 29256507)
19. Fouque D, Kalantar-Zadeh K, Kopple J, et al: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008;73:391-398. (Pubitemid 351186278)
20. Nakai S, Suzuki K, Masakane I, et al: Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial 2010;14:505-540.
21. Mafra D, Guebre-Egziabher F, Fouque D: Body mass index, muscle and fat in chronic kidney disease: questions about survival. Nephrol Dial Transplant 2008;23:2461-2466.
22. Honda H, Qureshi AR, Heimbürger O, et al: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-148. (Pubitemid 41828276)
23. Rambod M, Bross R, Zitterkoph J, et al: Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009;53:298-309.
24. Hung AM, Ellis CD, Shintani A, Booker C, Ikizler TA: IL-1β receptor antagonist reduces inflammation in hemodialysis patients. J Am Soc Nephrol 2011;22:437-442.
25. de Mutsert R, Grootendorst DC, Axelsson J, et al: Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant 2008;23:2957-2964.
26. Kalantar-Zadeh K, Kopple JD, Block G, et al: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001;38:1251-1263. (Pubitemid 34193111)
27. Sekikawa A, Ueshima H, Kadowaki T, et al: Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort. Am J Epidemiol 2007;165:617-624. (Pubitemid 46348375)